Funding for this research was provided by:
Fonden til Lægevidenskabens Fremme (17-L-0178)
Received: 30 September 2020
Accepted: 11 October 2021
First Online: 20 October 2021
: The study was approved by the ethical committee for the Capital Region of Denmark (H-17025043), the regional data safety committee for the capital region of Denmark (P-2019-712) and The Danish Data Protection Agency (2013-41-2618). All participants signed an informed consent form.
: Dr. Tupper reports personal fees from TEVA, outside the submitted work. Dr. Ulrik reports personal fees for lectures, advisory board meetings etc. from Sanofi, Novartis, AZ, GSK, Boehringer-Ingelheim, Chiesi, TEVA and ALK-Abello outside the submitted work.